Agilent Technologies Inc (A)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE
Market Cap: $49.05B
Last updated: Nov 17, 2026 at 11:05 AM ET
Agilent Technologies Inc (A) Financials: Revenue, Profit and Cash Flow
Agilent Technologies reported revenue of $6.95B for the fiscal year ended Oct 31, 2025, up 6.7% from the year before. That year, net income was $1.30B with a net margin of 18.8%, operating cash flow was $1.56B and free cash flow was $1.15B. The quarter ended Jul 31, 2026 had revenue of $1.88B and net income of $362.00M.
Revenue and Margins
The operating margin was 21.3% in the fiscal year ended Oct 2025. Over the 9 years to Oct 2025, revenue grew from $4.20B, a compound annual rate of 5.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Oct 2025 | $6.95B | +6.7% | 52.4% | 21.3% | 18.8% |
| Oct 2024 | $6.51B | -4.7% | 54.3% | 22.9% | 19.8% |
| Oct 2023 | $6.83B | -0.2% | 50.7% | 19.8% | 18.1% |
| Oct 2022 | $6.85B | +8.4% | 54.4% | 23.6% | 18.3% |
| Oct 2021 | $6.32B | +18.4% | 53.9% | 21.3% | 19.1% |
| Oct 2020 | $5.34B | +3.4% | 53.1% | 15.8% | 13.5% |
| Oct 2019 | $5.16B | +5.1% | 54.3% | 18.2% | 20.7% |
| Oct 2018 | $4.91B | +9.9% | 54.5% | 18.4% | 6.4% |
| Oct 2017 | $4.47B | +6.4% | 53.6% | 18.0% | 15.3% |
| Oct 2016 | $4.20B | N/A | 52.3% | 14.6% | 11.0% |
Income Statement
In the fiscal year ended Oct 2025, net income rose 0.8% from the year before. In the quarter ended Jul 2026, net income rose 7.7% from the same quarter a year earlier.
Annual
| Line item | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B | $5.34B | $5.16B | $4.91B | $4.47B | $4.20B |
| Cost of revenue | $3.31B | $2.98B | $3.37B | $3.13B | $2.91B | $2.50B | $2.36B | $2.23B | $2.07B | $2.00B |
| Gross profit | $3.64B | $3.54B | $3.46B | $3.72B | $3.41B | $2.84B | $2.81B | $2.68B | $2.40B | $2.20B |
| Research and development | $455.00M | $479.00M | $481.00M | $467.00M | $441.00M | $495.00M | $404.00M | $387.00M | $341.00M | $329.00M |
| Operating income | $1.48B | $1.49B | $1.35B | $1.62B | $1.35B | $846.00M | $941.00M | $904.00M | $807.00M | $615.00M |
| Net income | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B | $719.00M | $1.07B | $316.00M | $684.00M | $462.00M |
| EBITDA | $1.77B | $1.79B | $1.65B | $1.90B | $1.76B | $1.22B | $1.20B | $1.19B | $1.07B | $851.00M |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.88B | $1.83B | $1.80B | $1.86B | $1.74B | $1.67B | $1.68B | $1.70B | $1.58B | $1.57B | $1.66B | $1.69B |
| Gross profit | $1.04B | $990.00M | $946.00M | $990.00M | $888.00M | $866.00M | $899.00M | $916.00M | $855.00M | $856.00M | $908.00M | $915.00M |
| Operating income | $444.00M | $399.00M | $353.00M | $443.00M | $360.00M | $300.00M | $376.00M | $408.00M | $333.00M | $363.00M | $384.00M | $408.00M |
| Net income | $362.00M | $339.00M | $305.00M | $434.00M | $336.00M | $215.00M | $318.00M | $351.00M | $282.00M | $308.00M | $348.00M | $475.00M |
Balance Sheet
As of Oct 2025, total debt of $3.35B exceeded cash and equivalents by $1.56B.
Annual
| Line item | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $12.73B | $11.85B | $10.76B | $10.53B | $10.71B | $9.63B | $9.45B | $8.54B | $8.43B | $7.79B |
| Current assets | $4.59B | $3.96B | $4.19B | $3.78B | $3.80B | $3.42B | $3.19B | $3.85B | $4.17B | $3.63B |
| Cash and equivalents | $1.79B | $1.33B | $1.59B | $1.05B | $1.48B | $1.44B | $1.38B | $2.25B | $2.68B | $2.29B |
| Total liabilities | $5.99B | $5.95B | $4.92B | $5.23B | $5.32B | $4.75B | $4.70B | $3.97B | $3.59B | $3.55B |
| Short-term debt | $304.00M | $45.00M | $0 | $36.00M | $0 | $75.00M | $616.00M | $0 | $210.00M | $0 |
| Long-term debt | $3.05B | $3.35B | $2.73B | $2.73B | $2.73B | $2.28B | $1.79B | $1.80B | $1.80B | $1.90B |
| Shareholder equity | $6.74B | $5.90B | $5.84B | $5.30B | $5.39B | $4.87B | $4.75B | $4.57B | $4.83B | $4.24B |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $13.97B | $13.06B | $12.81B | $12.73B | $12.23B | $12.16B | $11.91B | $11.85B | $11.00B | $10.86B | $10.95B | $10.76B |
| Total liabilities | $6.60B | $5.94B | $5.91B | $5.99B | $5.86B | $6.02B | $5.89B | $5.95B | $5.09B | $4.64B | $4.76B | $4.92B |
| Cash and equivalents | $1.76B | $1.81B | $1.76B | $1.79B | $1.53B | $1.49B | $1.47B | $1.33B | $1.78B | $1.67B | $1.75B | $1.59B |
| Shareholder equity | $7.36B | $7.12B | $6.91B | $6.74B | $6.37B | $6.14B | $6.03B | $5.90B | $5.90B | $6.21B | $6.19B | $5.84B |
Cash Flow
In the fiscal year ended Oct 2025, free cash flow was 73.7% of operating cash flow. Dividends and share repurchases together came to 62.3% of it.
Annual
| Line item | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.56B | $1.75B | $1.77B | $1.31B | $1.49B | $921.00M | $1.02B | $1.09B | $889.00M | $793.00M |
| Capital expenditures | $407.00M | $378.00M | $298.00M | $291.00M | $188.00M | $119.00M | $155.00M | $177.00M | $176.00M | $139.00M |
| Free cash flow | $1.15B | $1.37B | $1.47B | $1.02B | $1.30B | $802.00M | $866.00M | $910.00M | $713.00M | $654.00M |
| Dividends paid | $282.00M | $274.00M | $265.00M | $250.00M | $236.00M | $222.00M | $210.00M | $191.00M | $170.00M | $150.00M |
| Share repurchases | $435.00M | $1.15B | $575.00M | $1.14B | $788.00M | $469.00M | $723.00M | $422.00M | $194.00M | $434.00M |
| Investing cash flow | -$394.00M | -$1.26B | -$310.00M | -$338.00M | -$749.00M | -$147.00M | -$1.59B | -$705.00M | -$304.00M | -$238.00M |
| Financing cash flow | -$715.00M | -$752.00M | -$930.00M | -$1.37B | -$696.00M | -$717.00M | -$299.00M | -$797.00M | -$202.00M | -$268.00M |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $519.00M | $277.00M | $268.00M | $545.00M | $362.00M | $221.00M | $431.00M | $481.00M | $452.00M | $333.00M | $485.00M | $516.00M |
| Capital expenditures | $80.00M | $76.00M | $93.00M | $93.00M | $103.00M | $114.00M | $97.00M | $93.00M | $92.00M | $103.00M | $90.00M | $84.00M |
| Free cash flow | $439.00M | $201.00M | $175.00M | $452.00M | $259.00M | $107.00M | $334.00M | $388.00M | $360.00M | $230.00M | $395.00M | $432.00M |
Frequently Asked Questions About A
What is Agilent Technologies' annual revenue?
Agilent Technologies reported revenue of $6.95B for the fiscal year ended Oct 31, 2025.
How fast is Agilent Technologies' revenue growing?
Revenue was up 6.7% for the fiscal year ended Oct 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 0.5%.
Is Agilent Technologies profitable?
Yes. Agilent Technologies reported net income of $1.30B for the fiscal year ended Oct 31, 2025, with a net margin of 18.8%.
How much free cash flow does A generate?
For the fiscal year ended Oct 31, 2025, operating cash flow of $1.56B minus capital expenditures of $407.00M produced free cash flow of $1.15B.
How much debt does Agilent Technologies have?
The balance sheet dated Oct 31, 2025 reported long-term debt of $3.05B, short-term debt of $304.00M and cash and equivalents of $1.79B.
A pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts